InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Elsbree David B, 董事. Insider active across 1 company, notably T2 Biosystems, Inc.. Cumulatively, 5 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €120. History available since 13 September 2024. The latest transaction was disclosed on 13 September 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
David B. Elsbree is a Board Member at T2 Biosystems, Inc. He contributes to the governance of the company by bringing his expertise in the health technology sector. David plays a key role in evaluating growth strategies and overseeing development initiatives. His industry experience is a valuable asset to T2 Biosystems' management team.